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Summary
T lymphocytes recognize discrete regions on an antigen . The specificity of the T cell responses
in three mouse strains of differing major histocompatibility complex (MHC) haplotype to a
protein antigen, lysozyme, was analyzed using a series ofpeptides that walk the antigen in single
amino acid steps. These peptide series were synthesized using the pin synthesis system, which
was modified to allow the peptides to be cleaved from the pins into a physiological buffer free
of toxic compounds . This methodology overcomes many of the problems associated with the
production ofpeptides for screening proteins for antigenic determinants. The T cell determinants
for the three strains were markedly different . This result points out the limitations ofalgorithms
predicting determinants without reference to the MHC, and the importance of the empirical
methodology. This analysis of the T cell response to lysozyme constitutes the most complete
study of reactivity to a foreign protein to date and illustrates many important features of antigen
recognition by T cells, e.g., presence ofmajor and minor determinant regions . The outer boundaries
of each immunogenic region, the determinant envelope, are difficult to define from recently
immunized lymph nodes because ofthe heterogeneity inT cell recognition . However, core sequences
common to all the immunogenic peptides in a continuous sequence can be easily defined .
U
nlike B cells, which can recognize free antigen, T cells
recognize fragments of denatured antigen bound to cell
surfaceMHC-encoded molecules. All immunogenic peptides
can bind an MHC molecule, and non-self peptides, which
bind with high affinity, are almost always immunogenic (1) .
Many regions of an antigen do not contain MHC-binding
sequences, and are therefore nonimmunogenic, while some
other regions, which appear capable of binding MHC, are
not immunogenic because of a deficient T cell repertoire.
Therefore, methods for detecting and/or predictingT cell-in-
ducing determinants are needed . Recently, a model of the
structure ofMHC molecules has been proposed based on crys-
tallographic data (2) . In this model, thereis no invariant peptide
binding surface shared among different MHC alleles. Both
the sides and the base ofthe putative antigen binding groove
are polymorphic, which implies that no common MHC-
binding motif should exist . Based on this information, we
favor the empirical approach for locatingT cell determinants
rather than predictive algorithms, whichmake no allowances
for MHC polymorphisms (3, 4) .
T cell determinant regions on an antigen can be defined
experimentally by testing primed T cells for reactivity to
different areas of the molecule. The reagents used include ho-
mologous proteins from other species, fragments of the whole
antigen produced by chemical or enzymatic degradation, and
overlapping peptides produced by solid phase synthesis (5) .
Additionally, DNA sequences corresponding to different parts
of the antigen may be expressed and T cells tested on the
resulting products (6) . The use ofa panel of overlapping syn-
thetic peptides is the most comprehensive approach and has
been used to analyze T cell responses to several small pro-
teins, including the malarial circumsporozoite protein (7),
hen egg-white lysozyme (HEL)l (8-11), and staphylococcal
nuclease (12) . Preparation ofsuch a panel, even applying proce-
dures for multiple peptide synthesis (13), is both very expen-
sive and time consuming. To minimize these costs, the number
of peptides synthesized is often reduced, so adjacent peptides
'Abbreviations used in this paper . HEL, hen egg-white lysozyme; LNC,
lymph node cells .
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consist of peptides corresponding to residues 1-20, 11-30,
21-40, etc .) . This has a number of disadvantages. First, de-
terminants may be missed if they span two peptides and are
larger than the peptide overlaps. Second, although reactivity
to a peptide may be detected, additional peptides need to be
synthesized to define the determinant boundaries . Therefore,
to reduce the time needed to prepare a complete panel ofpep-
tides, we have used an adaptation of the pin synthesis system,
which enables the rapid synthesis and cleavage from the solid
phase support of small amounts of many different peptides
(14) . Peptides are synthesized on pin heads inserted into the
wells of a 96-well plate. After deprotection, each peptide is
cleaved from the pin by exposure to neutral pH PBS, and
the peptide solutions can be added to T cell cultures with
no further treatment . The relative ease and speed ofthis meth-
odology allows the synthesis ofa peptide series that progresses
along the molecule in single amino acid steps, (e.g., 1-10,
2-11, 3-12, etc.), so that determinants will only be missed
if the peptides are too short . Also since each peptide is shifted
by only one residue, the boundaries of a determinant can be
accurately defined in the initial screening. It would be counter
productive for the peptides to require purification before use
since so many are produced . Therefore, the synthesis condi-
tions have been optimized so that the products can be directly
used . This is descried in detail elsewhere (14) . To test the
utility of these peptides, series of peptides of 10, 12, and 15
amino acids in length, corresponding to the complete chicken
lysozyme (HEL) sequence (Fig . 1), were tested on HEI~primed
lymph node cells from different mouse strains, whose HEL
response profile was known from earlier studies (8-11) .
Materials and Methods
Mice
￿
B10.A/SgSrJ, BALB.B and BALB/cJ mice were purchased
from The Jackson Laboratory (Bar Harbor, ME) and bred in our
animal facility.
LymphNodeProliferation Assays.
￿
Mice (8-14wk old) were im-
munized with 7 nmol (100 Wg) ofHEL in saline, in a 1 :1 emulsion
with CFA containing 1 mg/ml Mycobacterium tuberculosis strain
H37Ra, (Difco Laboratories, Detroit, MI) in the hind footpads .
After 10 d, the popliteal lymph nodes were removed and cell sus-
pensions prepared. The lymph node cells (LNC) were cultured in
96-well plates at 5 x 10 5 cells/well in HILL medium (Ventrex
Laboratories, Inc., Portland, ME) supplemented with 2mM gluta-
mine, 100 U/ml penicillin, 100 lAg/ml streptomycin, 5 hg/ml gen-
tamicin, and the indicated concentrations of antigen . For the pep-
tide series, one well per peptide was tested . The results were
confirmed by repeat experiments. Proliferation was measured by
addition of 1 fcCi of [3H]thymidine (International Chemical and
Nuclear, Irvine, CA) for the last 18 h ofa 5-d culture, and incorpo-
ration was assayed by liquid scintillation counting.
TCell Hybridoma Specificity Assays.
￿
TheTcell hybridomas were
derived by fusion ofT cells from the HELspecific T cell line A04H
and the thymoma BW5147 as described in detail previously (11) .
Specificity of hybridomas was tested by culturiug 105 hybrid cells
with 5 x 105 irradiated syngeneic spleen cells and antigen in
DMEM supplemented with 2mM glutamine, 1mM pyruvate, 0.05
mM 2-ME, and 10% FCS . The lysozymes were tested at 7-PM
concentration and peptide series tested at 5-10-p,M concentration .
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After 24 h in culture, 401Al of supernatant was removed and added
to 10'HT-2 cells. Proliferation was measured by [3H]thymidine in-
corporation 24 h later.
Peptide Synthesis.
￿
Control HEL peptides were synthesized by
Dr. J . Young at UCLA or Dr. M . McMillan and L . Williams at
USC, using a peptide synthesizer (430A ; Applied Biosystems, Inc .,
Foster City, CA) . The methodology has been described previously
(15) . The peptides were passed over a Sephadex G10 column (Phar-
macia Fine Chemicals., Piscataway, NJ), and the peptide fraction was
further purified as a single peak by HPLC on a preparative C8
column with a solvent system of 0.1% trifluoroacetic acid and an
increasing gradient ofacetonitrile. Peptide identity was confirmed
by amino acid composition analysis . The 74-96 preparation gave
a single major peak on analytical HPLC and, due to poor solu-
bility, was not purified further. The complete series ofHEL pep-
tides were synthesized using the pin synthesis technique. The pro-
cedure was modified as described in detail elsewhere (14) so that
the peptides could be cleaved from the pins. The first amino acid
residue added in each case was proline followedby Bodysine (Fmoc)-
OH . The Fmoc protecting group from the e amino group was
removed, and additional Fmoc-protected amino acids were added
in a stepwise fashion. The terminal amino group of each peptide
was acetylated . After removal ofall the protecting groups, cleavage
from the pins was performed by exposure to neutral pH (PBS),
under which conditions the COOH-terminal lysine-proline residues
underwent diketopiperazine formation. This methodology, unlike
that described previously (16), allows peptides of any sequence to
be cleaved . Peptide yield was estimated as described (14) . The ap-
proximate concentrations of the 10 amino acid series was 50 nmol
in 100 Etl, and for the 12 and 15 amino acid peptides, 10-20 nmol
in 150 ul . The peptides were added to the primed LNC to a final
concentration of 10,uM for the 10 amino acid peptides, and 5-10
uM for the 12 and 15 amino acid peptides .
Data Analysis.
￿
The complete series ofHEL peptides was tested
with one well for each peptide . The background proliferation to
peptide synthesis byproducts was assayed on the non-HEL pep-
tidesPLRQGGGGGG orGLAQGGGGGG with additional 000H-
terminal glycine residues for 12 and 15 amino acid sets . A peptide
was considered to have generated a positive response if, either on
its own it reproducibly stimulated a response of greater than the
background + 3 x SD, or it and an adjacent peptide induced a
response above this level . This low threshold was chosen to max-
imize sensitivity.No false positives were detected using these criteria .
Results
Specificity ofResponse Response by BIO.A andBALHB Mice .
￿
There
are numerous T cell determinants on HEL recognized by
B10.A (H-2') and BALRB (H-26) T cells, although the level
of reactivity to each after HEL priming is unequal . Respon-
siveness to major determinant regions can readily be detected
after priming with native HEL but responses to minor ones
are often very weak and may only be detected after peptide
immunization . The determinants recognized by B10.A mice,
in approximate order of importance, are contained within
the followingHEL peptides : 46-61, 20-35, 116-129, 34-45,
1-17, 74-82, and 85-96 ; and for BALB.B, 74-90, 30-53,
81-96, 20-35, and 46-61 (8-11) . The data in Fig . 2 show
reactivity detected by the peptide series in B10.A mice to the
major determinant regions within 46-61 and 20-35, with
lesser reactivity to the minor determinant regions withinChicken (HEL)
Guinea Fowl (NEL)
Bobwhite quail (BEL)
Japanese quail (JEL)
Turkey (TEL)
Ring-necked pheasant (REL)
Mouse
Chicken (HEL)
Guinea Fowl (NEL)
Bobwhite quail (BEL)
Japanese quail (JEL)
Turkey (TEL)
Ring-necked pheasant (REL)
Mouse
34-45, 1-17, 116-129, 85-96, and 74-82 . Responses to three
otherHEL peptides, 25-43, 90-110, and 105-120, have been
reported in the H-2k mouse strain C3H (9), and therefore,
B10.A mice would probably respond to immunization with
these peptides. However, these peptides contain minor de-
terminant regions only, requiring direct peptide priming to
stimulate a response, and so the failure of the peptide series
to recall reactivity in these regions was not unexpected .
BALRB mice can be seen to respond mainly to determinants
within the 30-53 and 74-96 peptides, and to a lesser extent
to determinants within 13-35 and 46-61 . In both strains re-
activity was usually detected using peptides of all three lengths,
although the 10-mer series barely detected reactivity with
20-35 in B10.A mice and stimulated only weak reactivity
to the 74-96 region in BALRB mice.
The levels ofresponsiveness to peptides in the series were
similar to those induced by corresponding peptides synthe-
sized by conventional techniques, with surprisingly few ex-
ceptions. Although reactivity to both the 74-90 and 81-96
determinant regions in BALRB was detected, the importance
of the 74-90 determinant region was underestimated . It is
possible that for this determinant the derivatization of the
-1 5 1 1 2 2 3 3 4 4 5 5 6 6
0 5 0 5 0 5 0 5 0 5 0 5
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Figure 1 .
￿
Amino acid sequences of lysozymes from different species. Thelysozyme sequences were obtained from the National Biomedical Research
Foundation data base. The peptide series synthesized corresponded to the HEL sequence shown except for the substitution of aspartic acid for asparagine
at position 103.
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NH2 and COON terminals (see Materials and Methods)
was deleterious. Alternatively, this sequence may be difficult
to synthesize, and the concentration of appropriate peptides
within this area may have beenlow . The response to the 46-61
region byBALB.B mice was not initially detected by the 12
amino acid-long peptide series in the experiment shown in
Fig. 2, although repeat experiments show reactivity in this
region using all three peptide series .
The data shown in Fig. 2 were obtained by testing one
well per peptide . The assays were performed in this way to
minimize the size of each experiment, which would be of
critical importance in screening long sequences. Rather than
set up replicate wells, complete experiments were repeated
using different groups of mice. The results obtained in re-
peat experiments were highly concordant (for example, see
Fig . 3) . The significance of reactivity in a single well is rein-
forced by reactivity in adjacent wells . This is seen especially
with the series of 15 mers, sincemore than one adjacent pep-
tide in a determinant region is capable of recalling prolifera-
tion . It should also be noted that the data obtained with ei-
ther the 10, 12, or 15 amino acid-long peptide series, which
were synthesized independently, are consistent with each other .
1 1 1 1 1 1 1
6 7 7 8 8 9 9 0 0 1 1 2 2 2
6 0 5 0 5 0 5 0 5 0 5 0 5 9This not only shows the reproducibility ofT cell prolifera-
tion between experiments but also demonstrates that different
lots of peptides yield reproducible results .
Specificity ofResponse by BALBlc Mice
￿
Previous investi-
gation ofthe HEIrinduced response in BALB/c mice showed
dominant reactivity to a single region within peptide 108-120
(17, 18) . However, because of the limitations of using an ar-
bitrarily chosen panel of peptides, other major determinant
regions could have been overlooked . Therefore, we examined
the specificity of the T cell response in BALB/c (H-2d) mice
using theHEL peptide series. The data shown in Fig. 4 clearly
confirm the presence of a dominant T cell determinant re-
gion within the previously defined area, and show that no
additional major determinant regions are recognized . Thus,
the response appears to be localized to one dominant region,
a part of the HEL molecule that BALB.B mice apparently
do not recognize. Comparison of the results from the three
612
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Figure 2 .
￿
The in vitro proliferative
response of HEILprimed B10.A and
BALB.B LNC to lysozyme peptides.
LNC from four to eight HEILimmu-
nized B10.A (a, b, and c) or BALB.B
(d, e, andf) mice were pooledand tested
for in vitro reactivity against 10 (a and
d),12 (b ande), and 15 (c andf ) amino
acid peptide series covering the whole
lysozyme molecule. The peptide number
shown at thebottom ofeach panel cor-
responds to the position of the NHZ-
terminal residue of the peptide in the
HEL sequence. The average non-HEL
peptide background response (cpm x
10- 3) offour to six wells t SD was :
a, 0 .7 ± 0.3 ; b, 7 .6 t 1 .3 ; c, 6 .2 ±
0 .6 ; d, 3 .6 ± 0 .7 ; e, 14 .1 ± 2; and f,
13 ± 1 .5 . The non-HEL backgroend
has been subtracted in each case. The
dashed linein each panel indicates three
times the standard deviation of the
non-HEL peptide background . The re-
sponses to controlHEL peptides (cpm
x 10-3) were : a, medium 0.5 and
HEL, 113 .5 ; b and c, medium 1.0 and
HEL, 142 .8 ; peptide (p) 20-35, 61 .5 ;
p30-53, 11 .0 ; p46-61, 18 .0 ; p74-96,
3 .0 ; and p11ó-129, 7 .9 ; d, medium, 4 .3 ;
HEL, 228.7; pl-17, 6 .1 ; p13-35, 24 .9 ;
p30-53, 50.6; p46-61, 36.2; and p74-
96, 104 .5 ; e, medium, 6 .0 ; HEL, 126 .2 ;
p20-35, 24.4; p30-53, 75 .0 ; p46-61,
28 .4 ; p74-96, 76.0; and p81-96, 15 .5 ;
f, medium 7 .0 ; HEL, 144.3 ; p20-35,
21 .8 ; p30-53, 59 .6 ; p46-61, 37.9; p74-
96, 103 .6 ; and p81-96, 15.8.
mouse strains shows a remarkable degree of variability in re-
sponse specificity. This reflects the genetic polymorphisms
in the MHC, which is presumably the result of strong evolu-
tionary pressure'for diversity in T cell responses. These and
similar data on the response to A repressor peptides (19) dem-
onstrate that different peptides are immunogenic in individual
strains and, consequently, that the only secure approach to
identify all determinant regions is an empirical one.
Specificity ofHEI reactive T Cell Hybridomas .
￿
The limita-
tions of the previous methodology for defining determinant
regions are apparent in that a high frequency of T cell hy-
bridomas isolated even from well-studied strains do not react
to theknown immunogenic peptides. For example, although
the peptide specificity of HEIrinduced responses in B10.A
mice has been extensively studied, three out of nine B10.A
T hybridomas derived in this laboratory .fail to react to any
of theknown HEL determinants (11) . Two of these hybrid-Figure 3 .
￿
Reproducibility of the in vitro proliferative response ofHEIT
primed B10.ALNC to pin-synthesized lysozyme peptides . LNC from four
to eight HEIAmmunized B10.A mice were pooled and tested for in vitro
reactivity against 12 (a and b) and 15 (c and d) amino acid series, synthe-
sized independently, covering the wholelysozyme molecule. a and c repre-
sent adifferent experiment from b andd. The peptide number at the bottom
of each panel corresponds to the position of the NHZ-terminal residue of
the peptide in the HEL sequence . The average non-HEL peptide back-
ground response (cpm x 10-3) of four to six wells ± SD was: a, 7 .6
± 1 .3 ; b, 8.9 ± 0 .8 ; c, 6.2 ± 0 .6 ; and d, 7 .8 ± 0.7 . The non-HEL pep-
tide background has been subtracted in each case . The responses to con-
trol conventional HEL peptides (cpm x 10-3 ) in Exp. 1 (a and c) were :
medium, 1.0 ; HEL, 142 .8 ; peptide (p)20-36, 61.5 ; p30-53, 11.0 ; p46-61,
18.0; p74-96, 3.0; and p116-129, 7.9 . The responses to conventional
HEL peptides (cpm x 10 -3 ) in Exp. 2 (b and d) were : medium, 0.8;
HEL, 162 .3 ; p20-35, 98 .4 ; p30-53, 16 .4 ; p46-61, 32.3; p74-96, 7 .9 ; and
p116-129, 15.8 .
omas, A04H.H9.1 andA04H.H5.3, which were HEL specific
and (IAk) restricted but did not react to any of the previ-
ously defined (I-Ak)-restricted determinants within peptides
13-35, 30-53, 46-61, 74-96, and 116-129, were examined
further. Initially, we completed the conventional approach
and tested the hybridomas on lysozymes from several different
bird species. One hybrid, A04H .H9.1, responded to HEL,
Japanese quail, bobwhite quail, and guinea fowl lysozymes
but not to turkey or ring-necked pheasant lysozymes (Table
1 a) . Comparison of the sequences of these lysozymes indi-
cates three possible locations for this determinant, which would
include residues 15, 41, or 73 . No putative sites for the deter-
minant recognized by the other hybrid could be defined since
it reacted strongly to each lysozyme. The data in Table 1 b
show that A04H.H9.1 reacted to the 10 amino acid peptide
73-82, which includes the polymorphic residue 73. The second
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Figure 4 .
￿
The peptide specificity of the HEITinduced proliferative re-
sponse in BALB/c mice. Four BALB/c mice were primed with HEL and
the draining lymph nodes removed after 10 d . TheLNC were pooled and
tested for in vitro reactivity against the 12 aminoacid (a) and the 15 amino
acid (b) peptide series . The peptide number shown at the bottom ofeach
panel corresponds to the position of the NHZ-terminal residue ofthe pep-
tide in the HEL sequence. The average non-HEL peptide background re-
sponse (cpm x 10- 3) *- SD was : (a) 8 .4 ± 1.1 and (b) 8.5 ± 0.8 . The
dashed line in each panel indicates three times the standard deviation of
the background. The background has been subtracted. The responses to
control peptides (cpm x 10 - 3) were : medium, 8 .1 ± 0 .5 ; HEL, 134 .2
± 24.1 ; and p108-120, 136.3 ± 7 .5 .
T hybrid, A04H.H5.3, was screened on the complete panel
of 15 amino acid peptides, and the data show that the deter-
minant recognized has the minimal sequence 52-62. The hy-
brid did not react to any of the 10 amino acid peptides (un-
published data) . Comparison of the species variants shows
that the only difference among the sequences in the 52-62
region is the conservative substitution of valine for isoleu-
cine in guinea fowl and bobwhite quail lysozymes, at residue
55 . The isoleucine at position 55 would not be expected to
affect reactivity since it appears to function as a spacer res-
idue in this determinant (20) . It is interesting to note that
residue 62 is different in the mouse and chicken sequences .
Discussion
The data in this paper clearly show the value of peptide
series produced by the modified pin synthesis technique inTable 1.
￿
Response ofHEL-speck T Cell Hybridomas to
Species Variant Lysoxymes and HEL Peptides
a .
b .
the detection of T cell determinant regions and the defini-
tion of their boundaries . Examination of the responses by
heterogeneous lymph node populations allows immunogenic
areas to be defined. However, in interpreting the data, it is
necessary to decide upon criteria for determining whether
a response is significant or not . Clearly, this decision is ar-
bitrary and will depend on anumber offactors. In this paper,
we have used the non-HEL peptide background plus three
times the standard deviation as the significance level, as de-
scribed in Materials and Methods . This low cutoffwas chosen
to maximize the sensitivity ofthe assay so as to detect minor
determinant regions as well as major determinant regions .
However, increasing the sensitivity will also increase the
chances ofdetecting false positives, although this did not occur
in our study. To reduce the possibility of false positives, more
stringent criteria canbe applied to determining positives. Using
two times the background as the cutoff level, major deter-
minant regions are identified in B10.A mice within the pep-
tides 46-61, 20-35, as well as the minor determinants 1-17,
34-45, and 116-129 . For BALB.B, determinant regions are
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identified within the major areas of 74-90, 30-53, and 81-96.
Such a stringent criterion may therfore be useful for selec-
tively detecting major determinant regions .
The data in Fig. 2 show that the adjacent 15 amino acid
peptides, from 31-45 through 38-52, recall a response in HEIr
primedBALB.B LNC . These peptides share residues 38-45,
and this defines a "core" sequence essential for immunoge-
nicity. Examination of the responses to the 10 and 12 amino
acid peptide series (Figs . 2, d and e) confirms the importance
of residues 38-45 . The two determinants within peptide 74-96
recognized by BALB.B mice are difficult to define because
they overlap but appear to have core sequences corresponding
to 77-85 and 83-90 . Several determinant core sequences can
be defined for B10.A mice. The size of the critical core se-
quence within the peptide 20-35 varies, with a core sequence
of 23-32 in the 10-mer series (Fig. 2 a), 24-31 in the 12-mer
series (Fig . 2 b), and 25-30 in the 15-mer series (Fig . 2 c) .
Variation in the core sequence also occurs for the other major
determinant region seen by B10.A mice and contained within
peptide 46-61. However, in this case it varies regardless of
the size of the peptides used and the critical sequence fluc-
tuates from 52-58 to 56-58, with all intermediate results .
We have arbitrarily designated 54-58 as the core sequence
for this determinant region . Core residues for determinants
that recall weaker and more variable responses are difficult
to define. This problem can be overcome by direct immuni-
zation with the appropriate peptide, which will induce strong
responses even to minor determinants.
It is particularly interesting that the determinants recog-
nized by the two hybridomas studied share all but one amino
acid residue with known (I-Ak)-restricted determinants ;
A04H.H9.1 required residue 73 in addition to 74-82, and
A04H.H5.3 required residue 62 in addition to the previously
defined 52-61 . This shows that the peptide products derived
from processing of the native antigen are not the same as
the experimental peptides that have been used. In fact, the
natural peptides may be quite large compared with the size
ofthe individual determinants they contain . Much attention
has been focused on defining minimal determinants, but clearly
this only has meaning for individual T cell clones . The most
immunologically relevant parameter is the functional size of
the "determinant envelope", which includes all the critical
residues related to each of the determinants recognized by
individual T cells in a continuous region .
It is important to differentiate between the termsT cell-in-
ducing determinant, determinant envelope, and core sequence.
A T cell determinant is the shortest peptide that stimulates
a response of normal magnitude in a T cell clone. This min-
imal peptide contains MHC-binding residues, which form
the agretope, and T cell contact residues, which form the
epitope (21) . The determinant envelope includes all the over-
lapping determinants recognized in a continuous stretch of
the sequence . The core sequence consists of the residues shared
by all the immunogenic peptides in a region . Nevertheless,
the core itself may not be immunogenic . Although this se-
quence contains residues absolutely required for antigenicity
by all clones, other residues on either side ofthe core sequence
may be needed for activation of individual T cell clones.
Antigen
in vitro
Response of T cell hybridomas
A04H.H9 .1 A04H.H5.3
cpm x 10-3
- 1.3 ± 0.8 1 .1 ± 0.2
HEL 96.6 ± 11 .1 83.5 ± 11 .5
BEL 134.8 ± 4 95.0 ± 8 .3
NEL 170.3 ± 10 96.9 ± 6.4
JEL 107.5 ± 7.3 202.2 ± 10.4
REL 1.5±0.3 87.6±5.5
TEL 1.5±0.4 194.0±3.0
74-96 0.9±0.4 1.1±0
- 1.6 ± 0.4 0.5 ± 0.1
HEL 48.5 ± 9 .4 64.0 ± 3.8
71-80 1.3
72-81 1.6
73-82 8.3
74-83 1.4
46-60 0.5
47-61 0.4
48-62 53.2
49-63 73.1
50-64 65.5
51-65 71.6
52-66 68 .9
53-67 0.5
54-68 0.4B10 .A
BALB .B
SALB/C
i^
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The determinant recognized by two (IAk)-restricted T
cell clones has been previously defined as 52-61 (20, 22) .
Amino acids 52, 58, and 61 were defined asMHC contact
residues, and 53, 56, and 57 as T cell contact residues . How-
ever, theT cell hybridoma, A04H.H5.3, recognizes a different
determinant, 52-62, within the determinant envelope . Analysis
of the response to this region by HEIrprimed B10.A LNC
defined a core sequence of 54-58 . The small size of this core
does not indicate a restricted diversity in the response. In fact,
it indicates the opposite, since given a core of 54-58, pep-
tides such as 44-58 and 54-68 would be expected to be im-
munogenic. Since both these peptides exclude at least one
residue needed to activate the three cloned T cell populations
studied, additional recognition phenotypes should exist . Thus,
the determinant envelope is almost certainly larger than 52-62,
presumably with some T cells recognizing a more NHZ-
terminal area within the determinant envelope and others
recognizing a more COOH-terminal area . The presence of
a set of overlapping minimal determinants has been described
elsewhere (23) . The distribution of individual determinants
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Summary of data on the specificity of the response of HEIrprimed LNC from B10.A, BALB.A and BALB/c mice. The core sequences
shown above as filled bars were defined as described in the text using the peptide series. Immunogenic HEL peptides are shown for each mouse strain
as open bars. The crosshatched bars under the B10.A mice are peptides that were found to be immunogenic in C3H mice by Adorini et al . (9), but
only contain minor determinant regions. The determinant region within peptide 25-43 is distinct from the determinant regions with core sequences
of25-30 and 37-42, since the former is I-Ek restricted and the latter are both I Ak restricted. In HEIrprimed BALB/c (I-Ad +, I-Ed+) mice, occasional
weak reactivity to the peptide 13-35, shown as a crosshatched bar, is observed . This peptide contains two major determinant regions in the related
strain B10.GD (I-Ad+, I-Ed - ) mice and the core sequences defined by the peptide series in the latter are 13-21 and 22-32 (unpublished data) . The
determinant regions predicted by the methods of Rothbard and Taylor (3) and Margalit et 41. (4) are also shown . In the case of the latter, only
regions with a high amphipathic score above 8 are shown, in accord with the authors recommendation . For the former, seven core regions are predicted,
1-4 (KVFG), 54-57 (GILQ), 61-64 (RWWC), 87-91 (DITAS), 97-100 (KIVS), and, in reverse order, 30-33 (CAAK) and 121-125 (QAWIR) .
within the envelope will lead to the "bell-shaped curve" pat-
tern of responses observed (see Figs . 2-4) as the peptide se-
ries progresses through a determinant envelope .
The outer boundaries of the determinant envelope are
difficult to delineate, but for all practical purposes, knowl-
edge of the core sequence, which can easily be defined, is
sufficient . A peptide centered on the core sequence will have
maximal reactivity for its length . Determinant envelopes can
be named according to their core sequence, rather than what
is done at present, after a peptide that fortuitously contains
some or all of the region . Thus, the (I-Ak)-restricted deter-
minant envelope with core sequence 54-58 was previously
defined by the tryptic peptide 46-61, which misses some of
the determinant envelope . From the vaccinologist's point of
view, it should be easy to compare the position of the core
sequences of determinant envelopes recognized by T cells from
MHC-disparate individuals . This will enable regions of the
antigen to be synthesized that will have the best chance of
being immunogenic in the largest number of individuals.
A summary of the data obtained in this study is shownin Fig . 5 . The filled bars show the determinant cores detected
using the peptide series. The open bars show peptides found
previously found to be immunogenicin the indicated strains.
The analysis usingthe peptide series clearly yields much more
information on the exact location of thedeterminantregion
than the previous analyses. The sites of determinant regions
predictedby the methods of Margalit et al . (4)and Rothbard
and Taylor (3) are also shown. These predictive algorithms
were only designed to detect regions of a protein likely to
be immunogenic. Each predictive algorithm accurately defines
some determinant regions, but misses others. Since neither
algorithm was designed to take into account variability in
MHC haplotype in the prediction of T cell determinants,
peptides synthesizedon the basisof these predictive methods
maybe immunogenic in oneor more strains, butnotin every
strain .
Peptides produced by themodified pin synthesis technique
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